Mitchell C. Posner to Janus Kinase 2
This is a "connection" page, showing publications Mitchell C. Posner has written about Janus Kinase 2.
Connection Strength
0.150
-
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers. Mol Cancer Ther. 2018 04; 17(4):732-739.
Score: 0.150
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.